Investor relations


Stock market

Financial reports

Quarterly report January–March 2022

Year-end report 2021

Quarterly report January–June 2021



Presentations

Redwood Pharma at Aktieportföljen Live 


ShareholdersNumber of sharesOwning (%)
Avanza Pension14 148 36414.7%
Martin Vidaeus2 462 4492.6%
Arne Andersson2 165 5042.3%
BNY Mellon SA/NV1 693 3771.8%
Carl Johan Mikael Thoren1 512 6011.6%
Johan Waldhe1 451 9481.5%
Sebastian Calinescu1 323 0001.4%
Fabian Karlsson1 288 4521.3%
Jens Erich Bechmann1 274 3751.3%
Nordnet Pensionsförsäkring AB1 188 3231.2%
Other shareholders67 694 84270.36%
In total96 203 235100.0%
December 31 2022

Shares

Nasdaq First North Growth Market: REDW
Redwoods share has been listed on Nasdaq First North Growth Market (since April 14 2021) under the ticker (REDW) and is traded through banks and stockbrokers. Previously listed on Spotlight Stock Market (since June 15 2016).

AGM 2022

Presentation held during AGM 2022

Information

Nasdaq First North Growth Market (Redwood Pharma)

Analysis

Analysguiden, Aktiespararna (November 15 2021)

Analysguiden, Aktiespararna (June 7 2021)

Analysguiden, Aktiespararna (Swedish) (May 21 2021)

Analysguiden, Aktiespararna (January 19 2021)

Rights Issuance Information

Memo Teaser – Rights Issuance 2017 Redwood Pharma AB (publ)

Memorandum – Rights Issuance 2017 Redwood Pharma AB (publ)

Subscription Form – Rights Issuance 2017 Redwood Pharma AB (publ)

Analyst Group’s Analysis of Redwood Pharma (NEW! June 13 2017)

IPO Memorandum

Financial calendar

Quarterly Report, Jan–Sep 2022
Oct 31 2022

Year-end-report 2022
Feb 15 2023

Quarterly Report, Jan–Mar 2023
May 9 2023

Annual General Meeting 2023
June 28 2023 

Certified Advisor: 

Erik Penser Bank
Tel: 08-463 80 00
Apelbergsgatan 27, Box 7405
103 91 Stockholm, Sverige